845 ABL503 (TJ-L14B), PD-L1×4–1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade

• Seung Hyuck Jeon,
• Su-Hyung Park,
• Jaeho Jung,
• Xuejun Liu,
• Hyunjoo Kim,
• Jaehyoung Jeon,
• Youngkwang Kim,
• Gihoon You,
• Kyungjin Park,
• Claire Xu

Affiliations

Seung Hyuck Jeon

2Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea

Su-Hyung Park

2Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea

Jaeho Jung

1ABL Bio, Inc., Seongnam-si, Republic of Korea

Xuejun Liu

4I-Mab Biopharma, Co., Ltd., San Diego, CA, USA

Hyunjoo Kim

1ABL Bio, Inc., Seongnam-si, Republic of Korea

Jaehyoung Jeon

1ABL Bio, Inc., Seongnam-si, Republic of Korea

Youngkwang Kim

1ABL Bio, Inc., Seongnam-si, Republic of Korea

Gihoon You

1ABL Bio, Inc., Seongnam-si, Republic of Korea

Kyungjin Park

1ABL Bio, Inc., Seongnam-si, Republic of Korea

Claire Xu

3I-Mab Biopharma, Co., Ltd., Lawrenceville Township, NJ, USA